Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5708977 | The Journal of Arthroplasty | 2016 | 18 Pages |
Abstract
Liposomal bupivacaine resulted in a decrease need for breakthrough pain medication, improved pain scores at 12Â hours, and an earlier time to ambulation compared to a combined femoral nerve block and periarticular bupivacaine injection.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Scott M. MD, Thea MS,